Home » BIOHEART, INC AND TRICARDIA, LLC SIGN PATENT LICENSING AGREEMENT
BIOHEART, INC AND TRICARDIA, LLC SIGN PATENT LICENSING AGREEMENT
Bioheart, Inc., a leader in developing cell therapies for heart repair, announced today the signing of a patent licensing agreement
with Tricardia, LLC of Eden Prairie, Minnesota for patents covering an improved injection needle. The needle will be attached to Bioheart's SR-200 MyoCath needle injection catheter system, which is capable of delivering biological solutions to the heart.
PR Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May